The VHA-UHC Alliance announced Monday an agreement to purchase for undisclosed terms a big part of MedAssets, as part of a three-way deal with Pamplona Capital Management, aiming to broaden its consulting capabilities for hospitals and health systems.
VHA-UHC has agreed to buy MedAssets’ spend and clinical resource management business, including that of consulting firm Sg2, from Pamplona as soon as Pamplona’s deal to buy the publicly traded company for about $2.7 billion closes.
Once the VHA-UHC agreement kicks in, Pamplona mainly will be left with MedAssets’ revenue cycle business, which would be combined with a health information management company it owns called Precyse.
The deal would be “transformative” for VHA-UHC upon closing, says Byron Jobe, president of strategic growth and marketing for VHA-UHC.
"MedAssets is a unique company,” Jobe says. “They have a number of capabilities that we find to be quite complementary with the capabilities in our organization."
VHA had merged with UHC earlier this year, and expects to rename itself in the coming weeks. Jobe also says the deal is expected to close early next year.
